Literature DB >> 18268407

Induction of benign symmetric lipomatosis (Launois-Bensaude syndrome) in a female patient after liver transplantation.

S Goetze1, M Hommann, P Elsner, M Kaatz.   

Abstract

Benign symmetric lipomatosis, also known as Madelung's disease or Launois-Bensaude syndrome, is a rare disease, the etiology of which is still unknown. The presence of multiple, symmetric, nonencapsulated lipomatous masses in the face, neck, upper arms and upper trunk is typical. Until now many causes have been discussed among which liver dysfunctions are described frequently. In up to 90% of patients, alcoholism is observed. In our case the Launois-Bensaude syndrome developed after liver transplantation in a 49-year-old female patient suffering from decompensated cirrhosis (Child-Pugh C score: 12 points). Shortly after the transplantation a slow progress in tissue-building appeared on both upper arms, cervical areas as well as in the face. During postsurgical prednisolone therapy, a massive increase in fluid in the tissue developed, which led to a discontinuation of this therapy regimen. In the further course there was an increase in weight of 20 kg. As far as we know, this case is the first description of the induction of a Launois-Bensaude syndrome following liver transplantation. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268407     DOI: 10.1159/000115968

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

1.  Madelung's disease in a patient with chronic alcohol abuse.

Authors:  Agata Zajkowska; Adam Garkowski; Piotr Czupryna; Anna Moniuszko; Sławomir Pancewicz; Joanna Zajkowska
Journal:  Arch Med Sci       Date:  2013-08-08       Impact factor: 3.318

2.  Madelung's disease in a patient with chronic renal insufficiency: a case report and review of literature.

Authors:  Beata Bergler-Czop; Dominika Wcisło-Dziadecka; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2014-04-22       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.